Baillie R. et al., Cancer stem cells in moderately differentiated oral tongue squamous cell carcinoma, [Epub ahead of print]., J. Clin Pathol., Apr 19, 2016 ➔

Hesbacher S. et al., RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells., [Epub ahead of print]., Oncotarget, Apr 18, 2016 ➔

Nowakowski R. et al., ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphom, [Epub ahead of print]., Future Oncol., Apr 18, 2016 ➔

Gonzalez-Rivera M. et al., Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial., [Epub ahead of print]., Breast Can Res. and Treat, Apr 15, 2016 ➔

Norton N. et al., Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors., [Epub ahead of print]., PLoS ONE, Apr 14, 2016 ➔

Castro N. et al., Adaptation of Laser Microdissection Technique for the Study of a Spontaneous Metastatic Mammary Carcinoma Mouse Model by NanoString Technologies., [Epub ahead of print]., PLoS ONE, Apr 14, 2016 ➔

Hu S. et al., Transcriptome Variability in Keratocystic Odontogenic Tumor Suggests Distinct Molecular Subtypes., [Epub ahead of print]., Sci. Reports, Apr 12, 2016 ➔

Townsend E.C. et al., The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice., [Epub ahead of print]., Cancer Cell, Apr 11, 2016 ➔

Romeo C. et al., HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells., [Epub ahead of print]., Mol. Can. Res., Apr 06, 2016 ➔

Parasramka M. et al., Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death., [Epub ahead of print]., European Urology Focus, Apr 02, 2016 ➔

Spears M. et al., A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial., [Epub ahead of print]., Oncotarget, Apr 01, 2016 ➔

Thompson E.M. et al., Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis., [Epub ahead of print]., The Lancet Oncology, Apr 01, 2016 ➔

Wuerstlein R. et al., The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer., [Epub ahead of print]., Curr. Med. Res. Opin., Mar 30, 2016 ➔

Griffiths O.L. et al., A genomic case study of mixed fibrolamellar hepatocellular carcinoma., [Epub ahead of print]., Annals Oncol., Mar 30, 2016 ➔

Shen F. et al., Novel Small-molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells., [Epub ahead of print]., Mol. Can. Res., Mar 21, 2016 ➔